Milestone Scientific Inc. (NYSEAMERICAN:MLSS) CFO Joseph D’agostino sold 20,000 shares of the stock in a transaction that occurred on Friday, January 8th. The stock was sold at an average price of $2.30, for a total transaction of $46,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Joseph D’agostino also recently made the following trade(s):

  • On Wednesday, January 13th, Joseph D’agostino sold 80,000 shares of Milestone Scientific stock. The stock was sold at an average price of $2.45, for a total transaction of $196,000.00.
  • On Monday, January 11th, Joseph D’agostino sold 40,000 shares of Milestone Scientific stock. The stock was sold at an average price of $2.37, for a total transaction of $94,800.00.
  • On Tuesday, January 5th, Joseph D’agostino sold 10,000 shares of Milestone Scientific stock. The stock was sold at an average price of $2.24, for a total transaction of $22,400.00.
  • On Tuesday, December 29th, Joseph D’agostino sold 30,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.97, for a total transaction of $59,100.00.
  • On Wednesday, December 16th, Joseph D’agostino sold 40,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.96, for a total transaction of $78,400.00.
  • On Wednesday, December 9th, Joseph D’agostino sold 10,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.88, for a total transaction of $18,800.00.
  • On Monday, December 7th, Joseph D’agostino sold 10,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.85, for a total transaction of $18,500.00.
  • On Monday, November 30th, Joseph D’agostino sold 31,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.65, for a total transaction of $51,150.00.

Shares of NYSEAMERICAN:MLSS opened at $2.46 on Thursday. Milestone Scientific Inc. has a 1 year low of $0.85 and a 1 year high of $3.05. The company’s 50 day simple moving average is $1.89.

Milestone Scientific (NYSEAMERICAN:MLSS) last announced its earnings results on Tuesday, November 17th. The medical instruments supplier reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.03. The business had revenue of $1.25 million for the quarter, compared to analysts’ expectations of $1.00 million.

Separately, Northland Securities began coverage on shares of Milestone Scientific in a research note on Wednesday, September 16th. They set a “market perform” rating on the stock.

Several large investors have recently made changes to their positions in MLSS. New York State Common Retirement Fund purchased a new position in shares of Milestone Scientific during the 2nd quarter valued at approximately $80,000. Bank of New York Mellon Corp purchased a new position in Milestone Scientific in the 2nd quarter valued at $142,000. Goldman Sachs Group Inc. purchased a new position in Milestone Scientific in the 2nd quarter valued at $41,000. American International Group Inc. purchased a new position in Milestone Scientific in the 2nd quarter valued at $42,000. Finally, Jane Street Group LLC purchased a new position in Milestone Scientific in the 2nd quarter valued at $118,000.

About Milestone Scientific

Milestone Scientific, Inc develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns.

Recommended Story: How is a price target determined?

Insider Buying and Selling by Quarter for Milestone Scientific (NYSEAMERICAN:MLSS)

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.